Sean Kendall

Sean Kendall is a Partner for Europe at ARCH Venture Partners, operating out of London, United Kingdom. Within the venture capital firm, he specializes in the life sciences sector, dedicating his efforts to identifying and evaluating emerging technologies that can transform global healthcare. Kendall works closely with early-stage portfolio companies, providing critical operating assistance to help them navigate the transition from foundational scientific discoveries to viable commercial enterprises. His primary investment focus centers on backing innovative platforms and novel therapeutics designed to prevent, detect, and cure a wide range of complex diseases. By leveraging his expertise in the European market, he supports the growth of biotechnology startups and helps scale their operations. Currently, Kendall focuses on advancing early-stage life science technologies and ensuring promising medical research receives the necessary capital to reach patients.